Abstract
In the present paper we have focussed on some different adsorbents for arsenic removal from aqueous media. Adsorbents were divided categorically in two different classes viz., synthetic adsorbents and natural adsorbents. Some of the synthetic adsorbents are found to be good for As(III) and some are good for As(V) removal. Similar results were also obtained for the natural adsorbents although removal efficiency depends on a number of factors. The efficiency of the adsorbents, merits and demerits were discussed in detail. Finally, we have discussed on some patented technologies and some potential filters.
Keywords: Synthetic adsorbents, natural adsorbents, arsenic, adsorption, isotherm, adsorption capacity, column study, regeneration, patent
Recent Patents on Engineering
Title: Adsorption Based Technologies for Arsenic Removal from Aqueous Environment: A Review
Volume: 4 Issue: 2
Author(s): Sanjoy Kumar Maji and Anjali Pal
Affiliation:
Keywords: Synthetic adsorbents, natural adsorbents, arsenic, adsorption, isotherm, adsorption capacity, column study, regeneration, patent
Abstract: In the present paper we have focussed on some different adsorbents for arsenic removal from aqueous media. Adsorbents were divided categorically in two different classes viz., synthetic adsorbents and natural adsorbents. Some of the synthetic adsorbents are found to be good for As(III) and some are good for As(V) removal. Similar results were also obtained for the natural adsorbents although removal efficiency depends on a number of factors. The efficiency of the adsorbents, merits and demerits were discussed in detail. Finally, we have discussed on some patented technologies and some potential filters.
Export Options
About this article
Cite this article as:
Kumar Maji Sanjoy and Pal Anjali, Adsorption Based Technologies for Arsenic Removal from Aqueous Environment: A Review, Recent Patents on Engineering 2010; 4 (2) . https://dx.doi.org/10.2174/187221210791233461
DOI https://dx.doi.org/10.2174/187221210791233461 |
Print ISSN 1872-2121 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4047 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypocretin Antagonists in Insomnia Treatment and Beyond
Current Pharmaceutical Design The Place of Somatostatin Analogs in the Diagnosis and Treatment of the Neuoroendocrine Glands Tumors
Recent Patents on Anti-Cancer Drug Discovery Nano-medicine Improving the Bioavailability of Small Molecules for the Prevention of Neurodegenerative Diseases
Current Pharmaceutical Design Mesothelioma - Update on Management
Current Respiratory Medicine Reviews Drug-Induced Peripheral Neuropathy: Diagnosis and Management
Current Cancer Drug Targets Pediatrics for Disability: A Comprehensive Approach to Children with Syndromic Psychomotor Delay
Current Pediatric Reviews An Update on Natural Occurrence and Biological Activity of Chromones
Current Medicinal Chemistry Development of Prolactin Receptor Antagonists: Same Goal, Different Ways
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Efalizumab
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Analysis of Adverse Events Related to 720 Cases of Neural Progenitor Cell Transplantation
CNS & Neurological Disorders - Drug Targets Dietary Approaches and Alternative Therapies for Rheumatoid Arthritis
Current Nutrition & Food Science Silybin and Silymarin - New and Emerging Applications in Medicine
Current Medicinal Chemistry Aspirin: from a Historical Perspective
Recent Patents on Cardiovascular Drug Discovery Characterization, ACE Inhibitory and Antioxidative Properties of Peptide Fractions Obtained from White Shrimp (<i>Litopenaeus vannamei</i>)
Current Bioactive Compounds Gastrodia Elata Bl Attenuates Methamphetamine-Induced Dopaminergic Toxicity Via Inhibiting Oxidative Burdens
Current Neuropharmacology Current Developments of Coumarin Compounds in Medicinal Chemistry
Current Pharmaceutical Design CGRP-Receptor Antagonism in Migraine Treatment
CNS & Neurological Disorders - Drug Targets Neuropeptide Receptor Ligands for the Treatment of Schizophrenia: Focus on Neurotensin and Tachykinins
Current Pharmaceutical Design Mixed Connective Tissue Disease (MCTD) and Undifferentiated Connective Tissue Disease (UCTD)
Current Rheumatology Reviews Update on Myositis Therapy: From Today’s Standards to Tomorrow’s Possibilities
Current Pharmaceutical Design